European Journal of Cancer

851 Periodical Search Results
You searched for "objective" AND "response" within European Journal of Cancer
New Search \| Edit Search \| Save Search \| Save Search as an E-mail Alert
Viewing 1-20 of 851 results Next 20>	Results Page: [1] 2 3 4 5 6 7 >

Display:

	Clinical benefit in oncology trials: Is this a patient-centred or tumour-centred end-point? , 22 June 2009 Pavlo Ohorodnyk, Elizabeth A. Eisenhauer, Christopher M. Booth European Journal of Cancer September 2009 (Vol. 45, Issue 13, Pages 2249-2252) Abstract \| Full Text \| Full-Text PDF (101 KB)
	Fulvestrant (Faslodex™) versus anastrozole for the second-line treatment of advanced breast cancer in subgroups of postmenopausal women with visceral and non-visceral metastases: combined results from two multicentre trials L. Mauriac, J.E. Pippen, J. Quaresma Albano, S.Z. Gertler, C.K. Osborne European Journal of Cancer June 2003 (Vol. 39, Issue 9, Pages 1228-1233) Abstract \| Full Text \| Full-Text PDF (196 KB)
	Treatment of metastatic malignant melanoma with dacarbazine plus fotemustine A Seeber, M Binder, A Steiner, K Wolff, H Pehamberger European Journal of Cancer December 1998 (Vol. 34, Issue 13, Pages 2129-2131) Abstract \| Full Text \| Full-Text PDF (60 KB)
	Predictive factors of response to first-line chemotherapy in 1426 women with metastatic breast cancer M. Robain, J.Y. Pierga, M. Jouve, B. Asselain, V. Diéras, P. Beuzeboc, T. Palangié, T. Dorval, J.-M. Extra, S. Scholl, P. Pouillart European Journal of Cancer December 2000 (Vol. 36, Issue 18, Pages 2301-2312) Abstract \| Full Text \| Full-Text PDF (134 KB)
	Dose intensification of epidoxorubicin and cyclophosphamide in metastatic breast cancer: a randomised study with two schedules of granulocyte-macrophage colony stimulating factor H Stöger, H Samonigg, M Krainer, M Ploszczynski, G Nirnberger, S Maca, W Hehenwarter, M Wirth, J Schüller, N Vavra, W Scheithauer, G Kornek, M Stierer, C.C Zielinski European Journal of Cancer March 1998 (Vol. 34, Issue 4, Pages 482-488) Abstract \| Full Text \| Full-Text PDF (156 KB)
	High activity and tolerability demonstrated for exemestane in postmenopausal women with metastatic breast cancer who had previously failed on tamoxifen treatment S. Kvinnsland, G. Anker, L.-Y. Dirix, J. Bonneterre, A.-M. Prove, N. Wilking, J.-P. Lobelle, O. Mariani, E. di Salle, A. Polli, G. Massimini European Journal of Cancer May 2000 (Vol. 36, Issue 8, Pages 976-982) Abstract \| Full Text \| Full-Text PDF (159 KB)
	Multicentre randomised phase III study comparing the same dose and schedule of cisplatin plus the same schedule of vinorelbine or gemcitabine in advanced non-small cell lung cancer A. Martoni, A. Marino, F. Sperandi, S. Giaquinta, F. Di Fabio, B. Melotti, M. Guaraldi, G. Palomba, P. Preti, A. Petralia, F. Artioli, V. Picece, A. Farris, L. Mantovani European Journal of Cancer January 2005 (Vol. 41, Issue 1, Pages 81-92) Abstract \| Full Text \| Full-Text PDF (333 KB)
	RFS2000 (9-nitrocamptothecin) in advanced small cell lung cancer, a phase II study of the EORTC New Drug Development Group C.J.A. Punt, M.J.A. de Jonge, S. Monfardini, G. Daugaard, W. Fiedler, B. Baron, D. Lacombe, P. Fumoleau European Journal of Cancer June 2004 (Vol. 40, Issue 9, Pages 1332-1334) Abstract \| Full Text \| Full-Text PDF (145 KB)
	FEC (5-fluorouracil, epidoxorubicin and cyclophosphamide) versus EM (epidoxorubicin and mitomycin-C) with or without lonidamine as first-line treatment for advanced breast cancer. A multicentric randomised study. Final results P. Pacini, M. Rinaldini, R. Algeri, A. Guarneri, E. Tucci, G. Barsanti, B. Neri, P. Bastiani, S. Marzano, C. Fallai European Journal of Cancer May 2000 (Vol. 36, Issue 8, Pages 966-975) Abstract \| Full Text \| Full-Text PDF (205 KB)
	Bolus injection (2–4min) versus short-term (10–20min) infusion of 5-fluorouracil in patients with advanced colorectal cancer: a prospective randomised trial B Glimelius, A Jakobsen, W Graf, Å Berglund, C Gadeberg, P Hansen, M Kjaer, N Brunsgaard, E Sandberg, B Lindberg, H Sellström, T Lorentz, L Påhlman, B Gustavsson European Journal of Cancer April 1998 (Vol. 34, Issue 5, Pages 674-678) Abstract \| Full Text \| Full-Text PDF (100 KB)
	The use of gonadotrophin-releasing hormone (GnRH) agonists in early and advanced breast cancer in pre- and perimenopausal women J.F.R. Robertson, R.W. Blamey European Journal of Cancer May 2003 (Vol. 39, Issue 7, Pages 861-869) Abstract \| Full Text \| Full-Text PDF (170 KB)
	Dacarbazine–vindesine versus dacarbazine–vindesine–cisplatin in disseminated malignant melanoma. A randomised phase III trial U Jungnelius, U Ringborg, S Aamdal, J Mattsson, U Stierner, C Ingvar, P Malmström, R Andersson, M Karlsson, K Willman, E Wist, G Bjelkengren, R Westberg European Journal of Cancer August 1998 (Vol. 34, Issue 9, Pages 1368-1374) Abstract \| Full Text \| Full-Text PDF (149 KB)
	Docetaxel in combination with 5-fluorouracil in patients with metastatic breast cancer previously treated with anthracycline-based chemotherapy: a phase I, dose-finding study A Lortholary, P Maillard, R Delva, M Boisdron-Celle, D Perard, L Vernillet, M Besenval, E Gamelin European Journal of Cancer September 2000 (Vol. 36, Issue 14, Pages 1773-1780) Abstract \| Full Text \| Full-Text PDF (110 KB)
	Capecitabine plus oxaliplatin (xelox) versus protracted 5-fluorouracil venous infusion plus oxaliplatin (pvifox) as first-line treatment in advanced colorectal cancer: A GOAM phase II randomised study (FOCA trial) Andrea Angelo Martoni, Carmine Pinto, Francesca Di Fabio, Giorgio Lelli, Fabiola Lorena Rojas Llimpe, Anna Lisa Gentile, Vita Mutri, PierLuigi Ballardini, Stefania Giaquinta, Edera Piana European Journal of Cancer December 2006 (Vol. 42, Issue 18, Pages 3161-3168) Abstract \| Full Text \| Full-Text PDF (176 KB)
	Response to chemotherapy has predictive value for further survival of patients with advanced non-small cell lung cancer: 10 years experience of the european lung cancer working party M Paesmans, J.P Sculier, P Libert, G Bureau, G Dabouis, J Thiriaux, J Michel, O Van Cutsem, R Sergysels, P Mommen, J Klastersky European Journal of Cancer December 1997 (Vol. 33, Issue 14, Pages 2326-2332) Abstract \| Full Text \| Full-Text PDF (125 KB)
	The role of chemotherapy and radiation in the management of biliary cancer: a review of the literature M Hejna, M Pruckmayer, M Raderer European Journal of Cancer June 1998 (Vol. 34, Issue 7, Pages 977-986) Abstract \| Full Text \| Full-Text PDF (103 KB)
	Should patients with advanced carcinomas be treated with chemotherapy? Contra: J Rouëssé, H Bourgeois European Journal of Cancer June 1998 (Vol. 34, Issue 7, Pages 962-964) Full Text \| Full-Text PDF (51 KB)
	Guidelines on endocrine therapy of breast cancerEUSOMA R.W. Blamey European Journal of Cancer March 2002 (Vol. 38, Issue 5, Pages 615-634) Full Text \| Full-Text PDF (208 KB)
	New response evaluation criteria in solid tumours: Revised RECIST guideline (version 1.1) , 22 December 2008 E.A. Eisenhauer, P. Therasse, J. Bogaerts, L.H. Schwartz, D. Sargent, R. Ford, J. Dancey, S. Arbuck, S. Gwyther, M. Mooney, L. Rubinstein, L. Shankar, L. Dodd, R. Kaplan, D. Lacombe, J. Verweij European Journal of Cancer January 2009 (Vol. 45, Issue 2, Pages 228-247) Abstract \| Full Text \| Full-Text PDF (761 KB)
	Update in methodology and conduct of cancer clinical trials P. Therasse, E.A. Eisenhauer, M. Buyse European Journal of Cancer July 2006 (Vol. 42, Issue 10, Pages 1322-1330) Abstract \| Full Text \| Full-Text PDF (182 KB)

Display:

Viewing 1-20 of 851 results Next 20>	Results Page: [1] 2 3 4 5 6 7 >
New Search \| Edit Search \| Save Search \| Save Search as an E-mail Alert